Fitness of in vitro selected Pseudomonas aeruginosa nalB and nfxB multidrug resistant mutants

Journal of Antimicrobial Chemotherapy

Volumn 50, Issue 5, 2002, Pages 657-664

  Sánchez, Patricia ^a   Linares, Juan Francisco ^a   Ruiz Díez, Beatriz ^b   Campanario, Ester ^a   Navas, Alfonso ^b   Baquero, Fernando ^c   Martínez, José L ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b MUSEO NACIONAL DE CIENCIAS NATURALES   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Bacterial fitness; Cost of resistance; Efflux pump; Multidrug resistance; Pseudomonas aeruginosa

Indexed keywords

ANTIBIOTIC AGENT; PHENAZINE DERIVATIVE; PROTEINASE; PYOCYANINE; PYOVERDINE;

ARTICLE; BACTERIAL METABOLISM; BACTERIAL VIRULENCE; BACTERIUM MUTANT; BIOFILM; CAENORHABDITIS ELEGANS; CELL SURVIVAL; CONTROLLED STUDY; IN VITRO STUDY; METABOLITE; MULTIDRUG RESISTANCE; NONHUMAN; PSEUDOMONAS AERUGINOSA; SPECIES DIFFERENCE; STRAIN DIFFERENCE; COMPARATIVE STUDY; DRUG EFFECT; GENETICS; MUTATION; PHYSIOLOGY;

DRUG RESISTANCE, MULTIPLE, BACTERIAL; MUTATION; PSEUDOMONAS AERUGINOSA;

EID: 0036849364     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkf185     Document Type: Article

References (48)

1. Quinn, J. P. (1998). Clinical problems posed by multiresistant nonfermenting Gram-negative pathogens. Clinical Infectious Diseases 27, S117-24.
2. Govan, J. R. & Deretic, V. (1996). Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiological Reviews 60, 539-74.
3. Li, X. Z., Livermore, D. M. & Nikaido, H. (1994). Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin. Antimicrobial Agents and Chemotherapy 38, 1732-41.
4. Li, X. Z., Nikaido, H. & Poole, K. (1995). Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 39, 1948-53.
5. Alonso, A., Rojo, F. & Martinez, J. L. (1999). Environmental and clinical isolates of Pseudomonas aeruginosa show pathogenic and biodegradative properties irrespective of their origin. Environmental Microbiology 1, 421-30.
6. Poole, K. (2000). Efflux-mediated resistance to fluoroquinolones in Gram-negative bacteria. Antimicrobial Agents and Chemotherapy 44, 2233-41.
7. Grkovic, S., Brown, M. H. & Skurray, R. A. (2001). Transcriptional regulation of multidrug efflux pumps in bacteria. Seminars in Cell and Developmental Biology 12, 225-37.
8. Kohler, T., Michea-Hamzehpour, M., Plesiat, P., Kahr, A. L. & Pechere, J. C. (1997). Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 41, 2540-3.
9. Alonso, A., Campanario, E. & Martinez, J. L. (1999). Emergence of multidrug-resistant mutants is increased under antibiotic selective pressure in Pseudomonas aeruginosa. Microbiology - UK 145, 2857-62.
10. Pumbwe, L. & Piddock, L. J. V. (2000). Two efflux systems expressed simultaneously in multidrug-resistant Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 44, 2861-4.
11. Ziha-Zarifi, I., Llanes, C., Kohler, T., Pechere, J. C. & Plesiat, P. (1999). In vivo emergence of multidrug-resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-OprM. Antimicrobial Agents and Chemotherapy 43, 287-91.
12. Jalal, S., Ciofu, O., Hoiby, N., Gotoh, N. & Wretlind, B. (2000). Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrobial Agents and Chemotherapy 44, 710-2.
13. Martinez, J. L. & Baquero, F. (2000). Mutation frequencies and antibiotic resistance. Antimicrobial Agents and Chemotherapy 44, 1771-7.
14. Poole, K., Krebes, K., McNally, C. & Neshat, S. (1993). Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. Journal of Bacteriology 175, 7363-72.
15. Poole, K., Gotoh, N., Tsujimoto, H., Zhao, Q., Wada, A., Yamasaki, T. et al. (1996). Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa. Molecular Microbiology 21, 713-24.
16. Andersson, D. I. & Levin, B. R. (1999). The biological cost of antibiotic resistance. Current Opinion in Microbiology 2, 489-93.
17. Giraud, E., Brisabois, A., Martel, J. L. & Chaslus-Dancla, E. (1999). Comparative studies of mutations in animal isolates and experimental in vitro and in vivo selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field. Antimicrobial Agents and Chemotherapy 43, 2131-7.
18. Pearson, J. P., Van Delden, C. & Iglewski, B. H. (1999). Active efflux and diffusion are involved in transport of Pseudomonas aeruginosa cell-to-cell signals. Journal of Bacteriology 181, 1203-10.
19. Kohler, T., van Delden, C., Curty, L. K., Michea-Hamzehpour, M. & Pechere, J. C. (2001). Overexpression of the MexEF-OprN multidrug efflux system affects cell-to-cell signaling in Pseudomonas aeruginosa. Journal of Bacteriology 183, 5213-22.
20. Bassler, B. L. (1999). How bacteria talk to each other: regulation of gene expression by quorum sensing. Current Opinion in Microbiology 2, 582-7.
21. de Kievit, T. R. & Iglewski, B. H. (2000). Bacterial quorum sensing in pathogenic relationships. Infection and Immunity 68, 4839-49.
22. Saier, M. H., Paulsen, I. T., Sliwinski, M. K., Pao, S. S., Skurray, R. A. & Nikaido, H. (1998). Evolutionary origins of multidrug and drug-specific efflux pumps in bacteria. FASEB Journal 12, 265-74.
23. Alonso, A., Sanchez, P. & Martinez, J. L. (2001). Environmental selection of antibiotic resistance genes. Environmental Microbiology 3, 1-9.
24. Tan, M. W., Mahajan-Miklos, S. & Ausubel, F. M. (1999). Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis. Proceedings of the National Academy of Sciences, USA 96, 715-20.
25. Srikumar, R., Kon, T., Gotoh, N. & Poole, K. (1998). Expression of Pseudomonas aeruginosa multidrug efflux pumps MexA-MexB-OprM and MexC-MexD-OprJ in a multidrug-sensitive Escherichia coli strain. Antimicrobial Agents and Chemotherapy 42, 65-71.
26. Okii, M., Iyobe, S. & Mitsuhashi, S. (1983). Mapping of the gene specifying aminoglycoside 3′-phosphotransferase II on the Pseudomonas aeruginosa chromosome. Journal of Bacteriology 155, 643-9
27. Atlas, R. M. (1993). Handbook of Microbiological Media. CRC Press, London.
28. Bagdasarian, M. & Bagdasarian, M. M. (1994). Gene cloning and expression. In Methods for General and Molecular Bacteriology (Gerhardt, P., Murray, R. G. E., Wood, W. A. & Krieg, N. R., Eds), pp. 406-17. American Society for Microbiology, Washington, DC, USA.
29. O'Toole, G. A. & Kolter, R. (1998). Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Molecular Microbiology 28, 449-61.
30. Cox, C. D. (1986). Role of pyocyanin in the acquisition of iron from transferrin. Infection and Immunity 52, 263-70.
31. Kessler, E., Israel, M., Landshman, N., Chechick, A. & Blumberg, S. (1982). In vitro inhibition of Pseudomonas aeruginosa elastase by metal-chelating peptide derivatives. Infection and Immunity 38, 716-23.
32. Rust, L., Messing, C. R. & Iglewski, B. H. (1994). Elastase assays. Methods in Enzymology 235, 554-62.
33. Romling, U., Wingender, J., Muller, H. & Tummler, B. (1994). A major Pseudomonas aeruginosa clone common to patients and aquatic habitats. Applied and Environmental Microbiology 60, 1734-8.
34. Neely, A. N. (2000). A survey of Gram-negative bacteria survival on hospital fabrics and plastics. Journal of Burn Care and Rehabilitation 21, 523-7.
35. Smith, S. M., Eng, R. H. & Padberg, F. T. (1996). Survival of nosocomial pathogenic bacteria at ambient temperature. Journal of Medicine 27, 293-302.
36. Singh, P. K., Schaefer, A. L., Parsek, M. R., Moninger, T. O., Welsh, M. J. & Greenberg, E. P. (2000). Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407, 762-4.
37. Drenkard, E. & Ausubel, F. M. (2002). Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature 416, 740-3.
38. Stewart, P. S. (1994). Biofilm accumulation model that predicts antibiotic resistance of Pseudomonas aeruginosa biofilms. Antimicrobial Agents and Chemotherapy 38, 1052-8.
39. Mahajan-Miklos, S., Tan, M. W., Rahme, L. G. & Ausubel, F. M. (1999). Molecular mechanisms of bacterial virulence elucidated using a Pseudomonas aeruginosa-Caenorhabditis elegans pathogenesis model. Cell 96, 47-56.
40. Evans, K., Passador, L., Srikumar, R., Tsang, E., Nezezon, J. & Poole, K. (1998). Influence of the MexAB-OprM multidrug efflux system on quorum sensing in Pseudomonas aeruginosa. Journal of Bacteriology 180, 5443-7.
41. De Vos, D., De Chial, M., Cochez, C., Jansen, S., Tummler, B., Meyer, J. M. et al. (2001). Study of pyoverdine type and production by Pseudomonas aeruginosa isolated from cystic fibrosis patients: prevalence of type II pyoverdine isolates and accumulation of pyoverdine-negative mutations. Archives in Microbiology 175, 384-8.
42. Okazaki, M., Onogawa, T., Araki, K., Egami, T., Furuya, N., Endo, N. et al. (1997). Isolation frequency and biological characteristics of the multiple-antibiotic resistant Pseudomonas aeruginosa isolated from clinical specimens. Kansenshogaku Zasshi 71, 1181-6.
43. Laurent, F., Lelievre, H., Cornu, M., Vandenesch, F., Carret, G., Etienne, J. et al. (2001). Fitness and competitive growth advantage of new gentamicin-susceptible MRSA clones spreading in French hospitals. Journal of Antimicrobial Chemotherapy 47, 277-83.
44. Bjorkman, J., Hughes, D. & Andersson, D. I. (1998). Virulence of antibiotic-resistant Salmonella typhimurium. Proceedings of the National Academy of Sciences, USA 95, 3949-53.
45. Bjorkholm, B., Sjolund, M., Falk, P. G., Berg, O. G., Engstrand, L. & Andersson, D. I. (2001). Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori. Proceedings of the National Academy of Sciences, USA 98, 14607-12.
46. Bjorkman, J., Nagaev, I., Berg, O. G., Hughes, D. & Andersson, D. I. (2000). Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science 287, 1479-82.
47. Cosson, P., Zulianello, L., Join-Lambert, O., Faurisson, F., Gebbie, L., Benghezal, M. et al. (2002). Pseudomonas aeruginosa virulence analyzed in a Dictyostelium discoideum host system. Journal of Bacteriology 184, 3027-33.
48. Hirakata, Y., Srikumar, R., Poole, K., Gotoh, N., Suematsu, T., Kohno, S. et al. (2002). Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa. Journal of Experimental Medicine 196, 109-18.